Cargando…
Immune microenvironments differ in immune characteristics and outcome of glioblastoma multiforme
Understanding the interactions between tumors and the host immune system holds great promise to uncover biomarkers for targeted therapies, predict the prognosis of patients and guide clinical treatment. However, the immune signatures of glioblastoma multiforme (GBM) remain largely unstudied in terms...
Autores principales: | Zhang, Botao, Shen, Rongfang, Cheng, Shujun, Feng, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558448/ https://www.ncbi.nlm.nih.gov/pubmed/31038851 http://dx.doi.org/10.1002/cam4.2192 |
Ejemplares similares
-
MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics
por: Shea, Amanda, et al.
Publicado: (2016) -
GARP as an Immune Regulatory Molecule in the Tumor Microenvironment of Glioblastoma Multiforme
por: Zimmer, Niklas, et al.
Publicado: (2019) -
Glioblastoma Multiforme in the over 70's: “To treat or not to treat with radiotherapy?”
por: Glynn, Aisling M., et al.
Publicado: (2019) -
Identification of Distinct Immune Subtypes in Colorectal Cancer Based on the Stromal Compartment
por: Shen, Rongfang, et al.
Publicado: (2020) -
Characterization of the immune microenvironment in brain metastases from different solid tumors
por: Jiang, Jinling, et al.
Publicado: (2020)